Therapeutics: Clostridium difficile toxin B (TcdB); poliovirus receptor-related 3 (PVRL3)

Cell culture studies suggest inhibiting the TcdB-PVRL3 interaction could help treat Clostridium difficile infection. In a human colon epithelial cell line treated with TcdB, PVRL3 knockout increased c...